Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
55 GBX | +5,77% |
|
+4,76% | -11,29% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 59 | 01/02/20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01/03/20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/19 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/02/19 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01/02/19 |
Corporate Officer/Principal | - | 01/06/20 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01/09/22 |
Caroline Diaz
LAW | General Counsel | - | 01/10/21 |
Matthew Casbon
SAM | Sales & Marketing | - | 24/08/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17/06/16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12/09/16 |
David Ebsworth
CHM | Chairman | 69 | 01/12/14 |
Director/Board Member | 71 | 10/09/15 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01/04/19 |
Director/Board Member | 68 | 10/09/15 | |
Chief Executive Officer | 59 | 01/02/20 | |
Director/Board Member | 59 | 01/09/23 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01/03/21 |
James Brady
BRD | Director/Board Member | 61 | 14/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 608 138 246 | 458 671 402 ( 75,42 %) | 0 | 75,42 % |
Coordinate società
![Indirizzo Verona Pharma plc(VRP)](https://cdn.zonebourse.com/static/address/34000093.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+19,76% | 126 Mrd | |
+24,94% | 118 Mrd | |
+25,04% | 27,87 Mrd | |
-17,06% | 20,95 Mrd | |
-14,87% | 16,92 Mrd | |
-13,72% | 16,18 Mrd | |
+10,88% | 14,84 Mrd | |
-47,10% | 14,79 Mrd | |
+53,07% | 14,08 Mrd |
- Borsa valori
- Azioni
- Azione VRNA
- Azione VRP
- Società Verona Pharma plc